Current Clinical Trials

DETECT-ASCEND 2
  1. Henry Tsai, MD
    Henry Tsai, MD
  2. Rancho Mirage, CA
  3. study started January 2022
  4. Henry Tsai, MD
  5. Accepting new patients

Description

Summary

This multi-center study is evaluating a blood test (also called a liquid biopsy) designed to detect multiple types of cancer at the earliest stages possible. A new version of the blood test has been developed and must now be tested. The new blood test, which is investigational, will provide researchers with more information, thereby possibly increasing chances for early cancer detection. The study anticipates enrolling 4500 Stage I-IV cancer patients.

Official Title

DETECT-ASCEND 2: Detecting Cancers Earlier Through Elective Plasma-Based CancerSEEK Testing-AScertaining Serial Cancer Patients to Enable New Diagnostic II. The study anticipates enrolling 4500 Stage I-IV cancer patients aged 50+.

Keywords

New or suspected cancer diagnosis

Lead Scientists at Eisenhower Health

Henry Tsai, MD
For Henry Tung-Yun Tsai, MD, MA, a Board Certified Hematologist and Medical Oncologist – specializing in the treatment colon cancer and other gastrointestinal cancers, medicine has always been a part of his life. Originally from Taiwan, Dr. Tsai’s father and sisters all have careers in medicine – ranging in specialties from pharmacy to general surgery.  After having moved from Taiwan at age 14, Dr. Tsai attended the University of Calif... more
less

For Henry Tung-Yun Tsai, MD, MA, a Board Certified Hematologist and Medical Oncologist – specializing in the treatment colon cancer and other gastrointestinal cancers, medicine has always been a part of his life. Originally from Taiwan, Dr. Tsai’s father and sisters all have careers in medicine – ranging in specialties from pharmacy to general surgery. 

After having moved from Taiwan at age 14, Dr. Tsai attended the University of California at Berkeley where he received his Bachelor of Arts in molecular and cell biology/neurobiology. He received a Master of Arts degree in medical sciences from Boston University and attended medical school at Wayne State University School of Medicine in Detroit, Michigan.

Upon graduating from medical school, he moved to Atlanta, Georgia for an internship, residency and a fellowship in Hematology/Oncology at Emory University. It was at Emory where Dr. Tsai grew to love his chosen specialty: cancer care.

“Yes, cancer care is one of the most difficult fields to practice,” says Dr. Tsai. “But, it is also the most stimulating and rewarding. There are days when I see my patients get better and I have experienced hope. I feel privileged to be a part of their process.”

Dr. Tsai has been a member of the American Medical Association, American College of Physicians, American Society of Clinical Oncology. He has been the local principle investigator for various clinical trials and has presented at workshops and symposiums across the United States. He has authored a book chapter and manuscript related to cancer.

Clinical Study Details

  1. Accepting new patients
  2. study started January 2022
  3. Blood Collection
  4. April 04, 2024